Age-Related Macular Degeneration (AMD) Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: A0836571CFAAEN
Market Monitor Global

Abstracts

Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected.

This report contains market size and forecasts of Age-Related Macular Degeneration (AMD) Therapeutics in Global, including the following market information:

Global Age-Related Macular Degeneration (AMD) Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Age-Related Macular Degeneration (AMD) Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Wet AMD Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Age-Related Macular Degeneration (AMD) Therapeutics include Amgen Inc., Bausch Health Companies, Inc., F. Hoffmann-La Roche Ltd., Novartis AG and Regeneron Pharmaceuticals Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Age-Related Macular Degeneration (AMD) Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Age-Related Macular Degeneration (AMD) Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Age-Related Macular Degeneration (AMD) Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Wet AMD
• Dry AMD

Global Age-Related Macular Degeneration (AMD) Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Age-Related Macular Degeneration (AMD) Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Research Institute
• Other

Global Age-Related Macular Degeneration (AMD) Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Age-Related Macular Degeneration (AMD) Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Age-Related Macular Degeneration (AMD) Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Age-Related Macular Degeneration (AMD) Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amgen Inc.
• Bausch Health Companies, Inc.
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Regeneron Pharmaceuticals Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size: 2021 VS 2028
2.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Age-Related Macular Degeneration (AMD) Therapeutics Players in Global Market
3.2 Top Global Age-Related Macular Degeneration (AMD) Therapeutics Companies Ranked by Revenue
3.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Age-Related Macular Degeneration (AMD) Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Age-Related Macular Degeneration (AMD) Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Age-Related Macular Degeneration (AMD) Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Age-Related Macular Degeneration (AMD) Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Age-Related Macular Degeneration (AMD) Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Wet AMD
  4.1.3 Dry AMD
4.2 By Type - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Research Institute
  5.1.5 Other
5.2 By Application - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue, 2017-2028
  6.3.2 US Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
  6.3.3 Canada Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Age-Related Macular Degeneration (AMD) Therapeutics Revenue, 2017-2028
  6.4.2 Germany Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
  6.4.3 France Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
  6.4.5 Italy Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
  6.4.6 Russia Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Age-Related Macular Degeneration (AMD) Therapeutics Revenue, 2017-2028
  6.5.2 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
  6.5.3 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
  6.5.6 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Age-Related Macular Degeneration (AMD) Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
  6.7.3 Israel Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028
  6.7.5 UAE Age-Related Macular Degeneration (AMD) Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Amgen Inc.
  7.1.1 Amgen Inc. Corporate Summary
  7.1.2 Amgen Inc. Business Overview
  7.1.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Major Product Offerings
  7.1.4 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Amgen Inc. Key News
7.2 Bausch Health Companies, Inc.
  7.2.1 Bausch Health Companies, Inc. Corporate Summary
  7.2.2 Bausch Health Companies, Inc. Business Overview
  7.2.3 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Major Product Offerings
  7.2.4 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Bausch Health Companies, Inc. Key News
7.3 F. Hoffmann-La Roche Ltd.
  7.3.1 F. Hoffmann-La Roche Ltd. Corporate Summary
  7.3.2 F. Hoffmann-La Roche Ltd. Business Overview
  7.3.3 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Major Product Offerings
  7.3.4 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 F. Hoffmann-La Roche Ltd. Key News
7.4 Novartis AG
  7.4.1 Novartis AG Corporate Summary
  7.4.2 Novartis AG Business Overview
  7.4.3 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Major Product Offerings
  7.4.4 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Novartis AG Key News
7.5 Regeneron Pharmaceuticals Inc.
  7.5.1 Regeneron Pharmaceuticals Inc. Corporate Summary
  7.5.2 Regeneron Pharmaceuticals Inc. Business Overview
  7.5.3 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Major Product Offerings
  7.5.4 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Regeneron Pharmaceuticals Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Age-Related Macular Degeneration (AMD) Therapeutics Market Opportunities & Trends in Global Market
Table 2. Age-Related Macular Degeneration (AMD) Therapeutics Market Drivers in Global Market
Table 3. Age-Related Macular Degeneration (AMD) Therapeutics Market Restraints in Global Market
Table 4. Key Players of Age-Related Macular Degeneration (AMD) Therapeutics in Global Market
Table 5. Top Age-Related Macular Degeneration (AMD) Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Age-Related Macular Degeneration (AMD) Therapeutics Product Type
Table 9. List of Global Tier 1 Age-Related Macular Degeneration (AMD) Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Age-Related Macular Degeneration (AMD) Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Age-Related Macular Degeneration (AMD) Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Age-Related Macular Degeneration (AMD) Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Age-Related Macular Degeneration (AMD) Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Age-Related Macular Degeneration (AMD) Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Inc. Corporate Summary
Table 31. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Offerings
Table 32. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Bausch Health Companies, Inc. Corporate Summary
Table 34. Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Offerings
Table 35. Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 37. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product Offerings
Table 38. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Novartis AG Corporate Summary
Table 40. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Offerings
Table 41. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Regeneron Pharmaceuticals Inc. Corporate Summary
Table 43. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Offerings
Table 44. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Age-Related Macular Degeneration (AMD) Therapeutics Segment by Type in 2021
Figure 2. Age-Related Macular Degeneration (AMD) Therapeutics Segment by Application in 2021
Figure 3. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2021
Figure 8. By Type - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Age-Related Macular Degeneration (AMD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)